PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
DRUG.AX vs. GNDQ.AX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

DRUG.AX vs. GNDQ.AX

Last updated Jul 18, 2026
Documentation

DRUG.AX (Betashares Global Healthcare Currency Hedged ETF) and GNDQ.AX (Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF) are both exchange-traded funds - DRUG.AX is a Health & Biotech Equities fund tracking the Nasdaq Global ex-Australia Healthcare Hedged AUD Index, while GNDQ.AX is a Global Equities fund actively managed by BetaShares. DRUG.AX is passively managed, while GNDQ.AX is actively managed. Over the past year, DRUG.AX returned 17.07% vs 21.89% for GNDQ.AX. At a 0.19 correlation, their price movements are largely independent.

Performance

DRUG.AX vs. GNDQ.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) and Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF (GNDQ.AX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DRUG.AX achieves a 1.49% return, which is significantly lower than GNDQ.AX's 9.74% return.

DRUG.AX

1D
1.89%
1M
5.32%
6M
0.23%
YTD
1.49%
1Y
17.07%
3Y*
6.21%
5Y*
4.03%
10Y*
—

GNDQ.AX

1D
-4.30%
1M
-6.38%
6M
9.42%
YTD
9.74%
1Y
21.89%
3Y*
—
5Y*
—
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

DRUG.AX vs. GNDQ.AX - Yearly Performance Comparison

2026 (YTD)20252024
DRUG.AX
Betashares Global Healthcare Currency Hedged ETF		1.49%11.83%-11.59%
GNDQ.AX
Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF		9.74%15.96%17.76%

Correlation

The correlation between DRUG.AX and GNDQ.AX is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Oct 15, 2024

0.19

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Betashares Global Healthcare Currency Hedged ETF

Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF

Often compared with DRUG.AX:
DRUG.AX vs. EX20.AXDRUG.AX vs. FOOD.AXDRUG.AX vs. FUEL.AXDRUG.AX vs. A200.AXDRUG.AX vs. AAA.AXDRUG.AX vs. ARMR.AXDRUG.AX vs. BNKS.AX
Often compared with GNDQ.AX:
GNDQ.AX vs. DHHF.AXGNDQ.AX vs. EX20.AXGNDQ.AX vs. FOOD.AXGNDQ.AX vs. FUEL.AXGNDQ.AX vs. GEAR.AXGNDQ.AX vs. GGUS.AXGNDQ.AX vs. A200.AX

Return for Risk

DRUG.AX vs. GNDQ.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
DRUG.AX
DRUG.AX Risk / Return Rank: 3838
Overall Rank
DRUG.AX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
DRUG.AX Sortino Ratio Rank: 4343
Sortino Ratio Rank
DRUG.AX Omega Ratio Rank: 3838
Omega Ratio Rank
DRUG.AX Calmar Ratio Rank: 3939
Calmar Ratio Rank
DRUG.AX Martin Ratio Rank: 3333
Martin Ratio Rank
GNDQ.AX
GNDQ.AX Risk / Return Rank: 2929
Overall Rank
GNDQ.AX Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
GNDQ.AX Sortino Ratio Rank: 3232
Sortino Ratio Rank
GNDQ.AX Omega Ratio Rank: 3131
Omega Ratio Rank
GNDQ.AX Calmar Ratio Rank: 2525
Calmar Ratio Rank
GNDQ.AX Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DRUG.AX vs. GNDQ.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) and Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF (GNDQ.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

DRUG.AXGNDQ.AXDifference
Sharpe ratioReturn per unit of total volatility
1.07
0.93

+0.14

Sortino ratioReturn per unit of downside risk
1.70
1.35

+0.35

Omega ratioGain probability vs. loss probability

1.20

1.17

+0.03

Calmar ratioReturn relative to maximum drawdown

1.56

0.92

+0.64

Martin ratioReturn relative to average drawdown

3.72

2.29

+1.44

DRUG.AX vs. GNDQ.AX - Sharpe Ratio Comparison

The current DRUG.AX Sharpe Ratio is 1.07, which is comparable to the GNDQ.AX Sharpe Ratio of 0.93. The chart below compares the historical Sharpe Ratios of DRUG.AX and GNDQ.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

DRUG.AX vs. GNDQ.AX - Drawdown Comparison

The maximum DRUG.AX drawdown since its inception was -26.79%, smaller than the maximum GNDQ.AX drawdown of -30.89%. Use the drawdown chart below to compare losses from any high point for DRUG.AX and GNDQ.AX.

Loading charts...

Drawdown Indicators

DRUG.AXGNDQ.AXDifference

Max Drawdown

Largest peak-to-trough decline

-26.79%

-30.89%

+4.10%

Max Drawdown (1Y)

Largest decline over 1 year

-10.69%

-23.50%

+12.81%

Max Drawdown (3Y)

Largest decline over 3 years

-20.63%

—

—

Max Drawdown (5Y)

Largest decline over 5 years

-20.63%

—

—

Current Drawdown

Current decline from peak

-2.61%

-9.40%

+6.79%

Average Drawdown

Average peak-to-trough decline

-5.17%

-6.91%

+1.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.52%

9.51%

-4.99%

Volatility

DRUG.AX vs. GNDQ.AX - Volatility Comparison

The current volatility for Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) is 6.29%, while Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF (GNDQ.AX) has a volatility of 8.57%. This indicates that DRUG.AX experiences smaller price fluctuations and is considered to be less risky than GNDQ.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

DRUG.AXGNDQ.AXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.29%

8.57%

-2.28%

Volatility (6M)

Calculated over the trailing 6-month period

11.71%

18.07%

-6.36%

Volatility (1Y)

Calculated over the trailing 1-year period

15.65%

23.33%

-7.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.95%

29.55%

-14.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.17%

29.55%

-13.38%

Dividends

DRUG.AX vs. GNDQ.AX - Dividend Comparison

DRUG.AX's dividend yield for the trailing twelve months is around 3.63%, more than GNDQ.AX's 1.56% yield.

PositionTTM20252024202320222021202020192018
DRUG.AX
Betashares Global Healthcare Currency Hedged ETF		3.63%0.00%2.84%0.00%0.00%4.49%0.62%0.28%3.37%
GNDQ.AX
Betashares Wealth Builder Nasdaq 100 Geared (30-40% LVR) Complex ETF		1.56%0.92%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

DRUG.AX and GNDQ.AX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DRUG.AX is categorized as Health & Biotech Equities, while GNDQ.AX is Global Equities.

Portfolio Optimizer

Find the right allocation for DRUG.AX and GNDQ.AX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer